{{Rsnum
|rsid=890
|Gene=GRIN2B
|Chromosome=12
|position=13562374
|Orientation=minus
|GMAF=0.3283
|Gene_s=GRIN2B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 32.7 | 47.8 | 19.5
| HCB | 5.1 | 35.8 | 59.1
| JPT | 5.3 | 26.5 | 68.1
| YRI | 0.0 | 4.1 | 95.9
| ASW | 0.0 | 28.1 | 71.9
| CHB | 5.1 | 35.8 | 59.1
| CHD | 0.9 | 27.5 | 71.6
| GIH | 7.9 | 42.6 | 49.5
| LWK | 0.0 | 13.6 | 86.4
| MEX | 31.0 | 55.2 | 13.8
| MKK | 4.5 | 33.3 | 62.2
| TSI | 25.7 | 45.5 | 28.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=22578441
|Title=Lack of an association between obsessive-compulsive disorder and polymorphisms in the 3' untranslated region of GRIN2B in a Chinese Han population
}}

{{PMID Auto
|PMID=18303265
|Title=Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease.
}}

{{PMID Auto
|PMID=19324536
|Title=Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder.
|OA=1
}}

{{PMID Auto
|PMID=20197096
|Title=Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.
|OA=1
}}

{{PMID Auto
|PMID=24114429
|Title=A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression
}}

{{PMID Auto
|PMID=23660601
|Title=Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}